Find clinical trials for Heart Disease in Cincinnati, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Heart Diseases
Coronary Artery Disease
Cardiovascular Diseases
Heart Failure
Myocardial Ischemia
Coronary Disease

Heart Disease trials near Cincinnati, OH, USA:

Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease (ECG-AID)

Atrial fibrillation is an abnormal beating of the heart that can lead to stroke or heart failure. Structural heart diseases...

Structural Heart Disease
Atrial Fibrillation
Device: Zio Patch Monitor
Device: Echocardiogram
Tempus AI
Tempus AI

Cincinnati, Ohio, United States and 2 other locations

The objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treati...

Heart Valve Diseases
Aortic Valve Disease
Device: Navitor Transcatheter Aortic Valve Implantation (TAVI) System
Device: Any Commercially Available Transcatheter Aortic Valve (CAV) System

Cincinnati, Ohio, United States and 20 other locations

Acute kidney injury (AKI) following cardiac surgery for congenital heart defects (CHD) in children affects up to 60% of high risk-patients a...

CHD - Congenital Heart Disease
Drug: Oxygen
Drug: Nitric Oxide

Phase 3

Cincinnati Children's Hospital Medical Center
Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States

The purpose of this study is to evaluate the device performance and monitor the safety and effectiveness of the Berlin Heart EXCOR Active Dr...

Transplant; Failure, Heart
Congenital Heart Disease
Device: EXCOR Active Driving System for Pediatric VAD
Berlin Heart

Cincinnati, Ohio, United States and 10 other locations

PumpKIN is a multicenter, prospective, single-arm feasibility study; Evaluating the investigational Jarvik 2015 VAD in pediatric patients with heart...

Active, not recruiting
Pediatric Heart Failure
Device: Surgical placement of the Jarvik 2015 VAD
Procedure: Surgical Placement of Jarvik 2015 VAD

Early Phase 1

Carelon Research

Cincinnati, Ohio, United States and 6 other locations

infusion of in patients with NYHA Class III heart failure. Patients with symptomatic congestive heart failure wil...

Heart Disease, Ischemic
Heart Failure, Diastolic
Biological: 3 x 10e13vg NAN-101

Phase 1

Asklepios Biopharmaceutical

Cincinnati, Ohio, United States and 3 other locations

This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo...

Single Ventricle Heart Disease
Drug: Placebo
Drug: Udenafil

Phase 3

Mezzion Pharmaceuticals

Cincinnati, Ohio, United States and 23 other locations

Evaluation of the safety and efficacy of the reSept ASD Occluder to treat patients with clinically significant secundum atrial septal defect

Heart Defects, Congenital
Cardiovascular Diseases
Device: reSept ASD Occluder
atHeart Medical

Cincinnati, Ohio, United States and 27 other locations

To demonstrate the safety and effectiveness of the Edwards Alterra Adaptive Prestent in conjunction with the Edwards SAPIEN 3 Transcatheter Heart...

Active, not recruiting
Pulmonary Disease
Congenital Heart Disease
Device: Edwards Alterra Adaptive Prestent with SAPIEN 3 THV
Edwards Lifesciences
Edwards Lifesciences

Cincinnati, Ohio, United States and 13 other locations

This is a Phase 2, multicenter, double-blind, sponsor unblinded, placebo-controlled, single-dose clinical study of CRD-4730 to evaluate the safety, t...

Heart Defects, Congenital
Heart Diseases
Drug: Placebo
Drug: CRD-4730

Phase 2

Cardurion Pharmaceuticals

Cincinnati, Ohio, United States and 11 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems